Our mission is to reduce worldwide visual disability and blindness by promoting the education and professional interaction of vitreoretinal specialists, providing optimal care for patients with vitreoretinal diseases, and encouraging, through clinical and basic research, the discovery and development of new means to further patient care.
Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attend so you can: present research, network with scientists, attend session and events, and browse the exhibit hall. Join the nearly half a million neuroscientists from around the world who have propelled their careers by presenting an abstract at an SfN annual meeting — the premier global neuroscience event.
Leber hereditary optic neuropathy (LHON) is a blinding mitochondrial disease that disproportionately affects young men. The diagnosis can be challenging with significant delays before a confirmed molecular diagnosis is reached. In this LHON Forum, we will discuss exciting developments in the field highlighting how a deeper understanding of the pathological mechanisms contributing to retinal ganglion cell loss is shaping the therapeutic landscape for this inherited optic nerve disorder.
Register for the LHON Forum 2022, November 28 at 20:00 hrs CET (11:00 am PST)
Register by contacting Gerard Bienfait at
A live broadcast from Doheny Eye Institute, Pasadena USA
Title: The current state of understanding and treatment for LHON
Block 1
Chair: Professor Patrick Yu Wai Man (Cambridge, UK)
Genetics: Professor Valerio Carelli (Bologna, Italy)
Mechanisms/pathways: Professor Alfredo A. Sadun (Los Angeles, USA)
Diagnose: Dr. Chiara La Morgia (Bologna, Italy)
Discussion
Block 2
Chair: Professor Patrick Yu Wai Man (Cambridge, UK)
LEROS: Professor Thomas Klopstock (Munich, Germany)
Gene therapy: Professor Nancy Newman (Atlanta, USA)
Window of opportunity/ chronic patients: Professor Marcela Votruba (Cardiff, UK)
Discussion
